Review Article: Genetic Polymorphism Studies and Insurgence of Human Genetic Diseases

Tabarak Sabah Jassim; Rusul Waleed Ali

doi:10.55544/jrasb.1.5.17

Authors

Tabarak Sabah Jassim Department of Medical Laboratory Technique, Dijlah University College, Baghdad, IRAQ.
Rusul Waleed Ali Department of Medical Laboratory Technique, Dijlah University College, Baghdad, IRAQ.

DOI:

https://doi.org/10.55544/jrasb.1.5.17

Keywords:

Polymorphism, human genome-wide polymorphism, Single nucleotide

Abstract

Single nucleotides polymorphism is the biological variant that affects people the most frequently (SNPs). Due of the link to hereditary illnesses, Polymorphisms are significant for hereditary investigations. Throughout this article, researchers examined a specific subset of SNPs that alter the sequencing of the related enzyme. Researchers created a brand-new technique that, beginning with sequencing data, can determine if a novel phenotypic resulting from an SNP is connected to a genetic abnormality. The greatest prevalent sort of genomic variability throughout the human genome is represented by solitary nucleotides polymorphism (SNPs). Understanding whether human genetic variants are associated with Chromosomal and complicated disorders is probably among a more essential objectives of SNP research. Non coding SNPs (NSSNPs), which cause solitary point mutations in molecules, are the subject of intense attention.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

REFERENCES

Al-Haggar, M., Madej-Pilarczyk, A., Kozlowski, L., Bujnicki, J. M., Yahia, S., Abdel-Hadi, D., Shams, A., Ahmad, N., Hamed, S., & Puzianowska-Kuznicka, M. (2012). A homozygous p.Arg527Leu LMNA mutation in the two unrelated Egyptian families causes overlapping mandibuloacral dysplasia and progeria syndrome. European Journal of Human Genetics, 20, 1134–1140.

Cao, R., Shi, Y., Chen, S., Ma, Y., Chen, J., Yang, J., Chen, G., & Shi, T. (2016). dbSAP: Single amino-acid polymorphism database for protein variation detection. Nucleic Acids Research, 45, 827–832.

Cordovado, S. K., Hendrix, M., Greene, C. N., Mochal, S., Earley, M. C., Farrell, P. M., Kharrazi, M., Hannon, W. H., & Mueller, P. W. (2012). CFTR mutation analysis and haplotype associations in CF patients. Molecular Genetics and Metabolism, 105, 249–254.

Giegling, I., Hartmann, A. M., Möller, H. J., & Rujescu, D. (2006). Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. Journal of Affective Disorders, 96, 75–81.

Glusman, G., Caballero, J., Mauldin, D. E., Hood, L., & Roach, J. C. (2011). Kaviar: An accessible system for testing SNV novelty. Bioinformatics, 27, 3216–3217.

Ji, G., Long, Y., Zhou, Y., Huang, C., Gu, A., & Wang, X. (2012). Common variants in mismatch repair genes are associated with increased risk of sperm DNA damage and male infertility. BMC Medicine, 10, 49.

Kimchi, S. C., Oh, J. M., Kim, I. W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007). A silent polymorphism in the MDR1 gene changes substrate specificity. Science, 315, 525–528.

Kujovich, J. L. (2011). Factor V Leiden thrombophilia. Genetics in Medicine, 13, 1–16.

Mohamed, A. A., Elsaid, O. M., Amer, E. A., Gerges, S. S., Saleh, M. A., El Abd, Y. S., Elosaily, H. H., Sleem, M. I., & El Shimy, A. (2017). Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases. Journal of Advanced Research, 8, 343–349.

Morita, A., Nakayama, T., Doba, N., Hinohara, S., Mizutani, T., & Soma, M. (2017). Genotyping of triallelic SNPs using TaqMan PCR. Molecular and Cellular Probes, 21, 171–176.

Singh, M., Singh, P., Juneja, P. K., Singh, S., & Kaur, T. (2018). SNP–SNP interactions within APOE genes, influencing the plasma lipids in postmenopausal osteoporosis. Rheumatology International, 31, 421–423.

Wei, Q., Wang, L., Wang, Q., Kruger, W. D., & Dunbrack, R. L., Jr. (2019). Testing computational prediction of missense mutation phenotypes: functional characterization of 204 mutations of human cystathionine beta synthase. Proteins, 78, 2058–2074.

Wilkinson, D. G., Francis, P. T., Schwam, E., & PayneParrish, J. (2019). Cholinesterase inhibitors used in the treatment of alzheimer’s disease: the relationship between pharmacological effects and clinical efficacy. Drugs & Aging, 21, 453–478.

Altman, R. B. and Klein, T. E. (2012) Challenges for biomedical informatics and pharmacogenomics. Ann. Rev. Pharmacol. Toxicol. 42,113-133.

Ambrose, H. J. (2002) SNPs and Pharmacogenomics. Pharmacogenomics 3, 583-586.

Barr, C. L.; Lichter, J. B. and Kidd, K. K. Approaches used to localize disease genes: Polymorphism mapping. In Molecular Diagnostics; Rapley R. and Walker M. R.; Eds; Blackwell Scientific Publications: Oxford, 66-75.

Behnke, D.; Raida, M.; Kliche, K. O. and Pichlmeier, U. (2002) Reply. Clin. Cancer Res. 8,1315-1316.

Beutler, E. (1993) Study of glucose-6-phosphate dehydrogenase: history and molecular biology. Am. J. Hematol. 42, 53-58.

Brookes, A. J.; Lehvaslaiho, H.; Siegfried, M.; Boehm, J. G.; Yuan, Y. P.; Sarkar, C. M.; Bork, P. and Ortigao, F. (2020) HGBASE: a database of SNPs and other variations in and around human genes. Nucleic Acids Res. 28, 356-360.

Buetow, K. H.; Edmonson, M.; MacDonald, R.; Clifford, R.; Yip, P. and Kelley, J. Little, D.P.; Strausberg, R.; Koester, H.; Cantor, C. R. and Braun, A. (2020) High-throughput development and characterization of a genome wide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. USA 98, 581-584.

Cairncross, J. G.; Ueki, K.; Zlatescu, M. C.; Lisle, D. K.; Finkelstein, D. M.; Hammond, R. R.; Silver, J. S.; Stark, P. C.; Macdonald, D. R.; Ino, Y; Ramsay, D. A. and Louis, D. N. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 90, 1473- 1479.

Davies, P. (1986) The genetics of Alzheimer's disease: a review and a discussion of the implications. Neurobiol. Aging. 7, 459-466.

Desta, Z.; Wu, G. M.; Morocho, A. M.; Flockhart, D. A. (2016) The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6. Drug Metab. Dispos. 3, 336-343.

Desta, Z.; Zhao, X.; Shin, J. G.; Flockhart, D. A. (2002) Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin. Pharmacokinet. 41, 913-958.

Drysdale, C. M.; McGraw, D. W.; Stack, C. B.; Stephens, J. C.; Judson, R. S.; Nandabalan K.; Arnold K.; Ruano G. and Liggett, S. B. (2016) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. USA 97, 10483-10488.

Ezquerra, M.; Lleo, A.; Castellvi, M.; Queralt, R.; Santacruz, P.; Pastor, P.; Molinuevo, J. L.; Blesa, R. and Oliva, R. (2017) A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease. Arch. Neurol. 60, 1149-1151.

Fischer, J.; Schwab, M.; Eichelbaum, M. and Zanger, U. M. (2015) Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography. Genet. Test. Summer 7, 97-105.

Fredman, D.; Siegfried, M., Yuan, Y. P., Bork, P.; Lehvaslaiho, H. and Brookes, A. J. (2015) HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res. 30, 387-391.

Gross, E.; Seck, K.; Neubauer, S.; Mayr, J.; Hellebrand, H.; Ratanaphan, A.; Lutz, V.; Stockinger, H. and Kiechle, M. (2017) High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism. Int. J. Oncol. 22, 325-332.

Hakonarson, H.; Bjornsdottir, U. S.; Halapi, E.; Palsson, S.; Adalsteinsdottir, E.; Gislason, D.; Finnbogason, G.; Gislason, T.; Kristjansson, K.; Arnason, T.; Birkisson, I.; Frigge, M. L.; Kong, A.; Gulcher, J. R. and Stefansson, K. (2018) A major susceptibility gene for asthma maps to chromosome 14q24. Am. J. Hum. Genet. 71, 483-491.

Hill, A. V. S.; Allsopp, C. E. M.; Kwiatkowski, D.; Anstey, N. M.; Twumasi, P.; Rowe, P. A.; Bennett, S.; Brewster, D.; McMichael, A. J. and Greenwood, B. M. (1991) Common West African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600.

Hubbard, T.; Barker, D.; Birney, E.; Cameron, G.; Chen, Y.; Clark, L.; Cox, T.; Cuff, J.; Curwen, V.; Down, T.; Durbin, R.; Eyras, E; Gilbert, J; Hammond, M; Huminiecki, L.; Kasprzyk, A.; Lehvaslaiho, H.; Lijnzaad, P.; Melsopp, C.; Mongin, E.; Pettett, R.; Pocock, M.; Potter, S.; Rust, A.; Schmidt, E.; Searle, S.; Slater, G.; Smith, J.; Spooner, W.; Stabenau, A.; Stalker, J.; Stupka, E.; Ureta-Vidal, A.; Vastrik, I. and Clamp, M. (2018) The Ensembl genome database project. Nucleic Acids Res. 30, 38-41.

Kent, W. J.; Sugnet, C. W.; Furey, T. S.; Roskin, K. M.; Pringle, T. H.; Zahler, A. M. and Haussler, D. (2002) The human genome browser at UCSC. Genome Res. 12:996-1006.

Kuhara, T.; Ohdoi, C.; Ohse, M.; van Kuilenburg, A. B.; van Gennip, A. H.; Sumi, S.; Ito, T.; Wada, Y. and Matsumoto, I. (2017) Rapid gas chromatographic-mass spectrometric diagnosis of dihydropyrimidine dehydrogenase deficiency and dihydropyrimidinase deficiency. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 792, 107-115.

Lazarou, J.; Pomeranz, B. H. and Corey, P. N. (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279, 1200-1205.

Luzzatto, L. and Mehta, A. (1995) Glucose 6-phosphate dehydrogenase deficiency. In The Metabolic and Molecular Bases of Inherited Disease; Scriver, C. R.; Beaudet, A. L.; Sly, W. S. and Valle, D.; Eds.; McGraw-Hill, Inc: New York, pp. 3367-3398.

McKusick, V. A. (2013) Online Mendelian Inheritance in Man (OMIM). Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), http//www3.ncbi.nlm.nih.gov/omim/ McLeod,

H. L.; Krynetski, E. Y.; Relling, M. V. and Evans W. E. (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14, 567-572.

Mullis, K. B. and Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 155, 335-350.

Nei, M. and Roychoudhury, A. K. (2013) Evolutionary relationships of human populations on a global scale. Mol. Biol. Evol. 10, 927-943.

Pettipher, R. and Cardon, L. R. (2002) The application of genetics to the discovery of better medicines. Pharmacogenomics 3, 257-263.

Pullarkat, S. T.; Stoehlmacher, J.; Ghaderi, V.; Xiong, Y. P.; Ingles, S. A.; Sherrod, A.; Warren, R.; Tsao-Wei, D.; Groshen, S. and Lenz, H. J. (2001) Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. 1, 65-70.

Race, R. R. and Sanger, R. (1975) Blood Groups in Man (Blackwell, Oxford), 6th Ed. Raida, M.; Schwabe, W.; Hausler, P.; Van Kuilenburg, A. B.; Van Gennip, A. H.; Behnke, D. and Hoffken, K. (2001) Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls. Clin. Cancer Res. 7, 2832-2839.

Sachidanandam, R.; Weissman, D.; Schmidt, S. C.; Kakol, J. M.; Stein, L. D.; Marth, G.; Sherry, S.; Mullikin, J. C.; Mortimore, B. J.; Willey, D. L.; Hunt, S. E.; Cole, C. G.; Coggill, P. C.; Rice, C. M.; Ning, Z.; Rogers, J.; Bentley, D. R.; Kwok, P. Y.; Mardis, E. R.; Yeh, R. T.; Schultz, B.; Cook, L.; Davenport, R.; Dante, M.; Fulton, L.; Hillier, L.; Waterston, R. H.; McPherson, J. D.; Gilman, B.; Schaffner, S.; Van Etten, W. J.; Reich, D.; Higgins, J; Daly, M. J.; Blumenstiel, B.; Baldwin, J.; Stange-Thomann, N.; Zody, M. C.; Linton, L.; Lander, E. S. and Altshuler, D. (International SNP Map Working Group). (2017) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928-933.

Sarkar, C.; Ortigao, F. R.; Gyllensten, U. and Brookes, A. J. (2016) Human genetic bi-allelic sequences (HGBASE), a database of intragenic polymorphisms. Mem. Inst. Oswaldo Cruz. 93, 693-694.

Saunders, A. M. (2001) Gene identification in Alzheimer's disease. Pharmacogenomics 2, 239-249. Stajich, J. E.; Block, D.; Boulez, K.; Brenner, S. E.; Chervitz, S. A.; Dagdigian, C.; Fuellen, G.; Gilbert, J. G.; Korf, I.; Lapp, H.; Lehvaslaiho, H.; Matsalla, C.; Mungall, C. J.; Osborne, B. I.; Pocock, M. R.; Schattner, P.; Senger, M.; Stein, L. D.; Stupka, E.; Wilkinson, M. D and Birney, E. (2002) The Bioperl toolkit: Perl modules for the life sciences. Genome Res. 12, 1611-1618.

Stein, L. D. (2002) The Generic Genome Browser: A building block for a model organism system database. Genome Res. 12, 1599-1610. Stein, L. D. and Thierry-Mieg, J. (1998) Scriptable access to the Caenorrhabditis elegans genome sequence and other ACeDB databases. Genome Res. 8, 1308-1315.

Thorisson, G. D. and Stein, L. D. (2003) The SNP Consortium website: past, present and future. Nucleic Acids Res. 31, 124-127

Van Kuilenburg, A. B. P.; Haasjes, J.; Richel, D. J.; Zoetekouw, L.; Van Lenthe, H.; De Abreu, R. A.; Maring, J. G.; Vreken, P. and van Gennip, A. H. (2000) Clinical implications of dihydropyrimidine de-hydrogenase (DPD) deficiency in patients with severe 5- fluorouracil-associated toxicity: iden-tification of new mutations in the DPD gene. Clin. Cancer Res. 6, 4705-4712.

Vesell, E. S. and Penno, M. B. (1983) Assessment of methods to identify sources of interindividual pharmacokinetic variations. Clin. Pharmacokinet. 8, 378-409.

Dai J. Clinical and Genetic Associations Between Lung Cancer and Chronic Obstructive Pulmonary Disease. University of Sheffield; 2017

Schwartz AG. Genetic epidemiology of cigarette smoke–induced lung disease. Proceedings of the American Thoracic Society. 2012;9(2):22-26

Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews. 2016;37(5):467-520. DOI: 10.1210/er.2015-1104

Huang E et al. Genome-wide screen for universal individual identification SNPs based on the HapMap and 1000 genomes databases. Scientific Reports. 2018;8(1):1-6

Yousefi S et al. A SNP panel for identification of DNA and RNA specimens. BMC Genomics. 2018;19(1):1-12

Teama S. DNA polymorphisms: DNA-based molecular markers and their application in medicine. In: Genetic Diversity and Disease Susceptibility, i, Number Tourism. InTech; 2018. p. 13

Hampel H, Bennett RL, Buchanan A, et al. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of genetic Counselors: Referral indications for cancer predisposition assessment. Genetics in Medicine. 2015

Findlay GM, Daza RM, Martin B, et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature. 2018;562(7726):217-222.

Jo B, Choi S. Introns: The functional benefits of introns in genomes. Genomics & Informatics. 2015;13(4):112-118

Melaiu O, Gemignani F, Landi S. The genetic susceptibility in the development of malignant pleural mesothelioma. Cancer Chemotherapy and Pharmacology. 2018;10(Suppl. 2):246-252

Singh M, Tyagi SC. Ocular disorders. Genes and genetics in eye diseases: A genomic medicine approach for investigating hereditary and inflammatory ocular disorders. International Journal of Ophthalmology. 2018;11(1):117-134

Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Thieme E-Journals-Seminars in Thrombosis and Hemostasis. 2017;42(8):808-820

Jackson M, Marks L, May GHW, Wilson JB. The genetic basis of disease. Essays in Biochemistry. 2018;62(December):643-723

Chakravarti A. Perspectives on human variation through the lens of diversity and race. Cold Spring Harbor Perspectives in Biology. 2015;7, a023358:1-14

Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, et al. Research article Crispr/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & Cell. 2015;6(5):363-372

Teama S. DNA polymorphisms: DNA-based molecular markers and their application in medicine. In: Genetic Diversity and Disease Susceptibility, i, Number Tourism. InTech; 2018. p. 13

Palmer LJ, Cardon LR. Shaking the tree: Mapping complex disease genes with linkage disequilibrium. Lancet. 2005;366(9492):1223-1234

Yousefi S et al. A SNP panel for identification of DNA and RNA specimens. BMC Genomics. 2018;19(1):1-12

Huang E et al. Genome-wide screen for universal individual identification SNPs based on the HapMap and 1000 genomes databases. Scientific Reports. 2018;8(1):1-6

Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews. 2016;37(5):467-520. DOI: 10.1210/er.2015-1104

Schwartz AG. Genetic epidemiology of cigarette smoke–induced lung disease. Proceedings of the American Thoracic Society. 2012;9(2):22-26

Dai J. Clinical and Genetic Associations Between Lung Cancer and Chronic Obstructive Pulmonary Disease. University of Sheffield; 2017

Young, A. I. et al. Mendelian imputation of parental genotypes for genome-wide estimation of direct and indirect genetic effects. Preprint at bioRxiv https://doi.org/10.1101/2020.07.02.185199v1 (2020).

Chheda, H. et al. Whole-genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland and United Kingdom. Eur. J. Hum. Genet. 25, 477–484 (2017).

Herzig, A. F. et al. Strategies for phasing and imputation in a population isolate. Genet. Epidemiol. 42, 201–213 (2018).